(Q40975302)

25 September 2017

1 reference

title

Cancer cachexia: pathophysiological mechanisms (English)

1 reference

25 September 2017

1 reference

Gough DB

1

1 reference

25 September 2017

Heys SD

series ordinal

2

1 reference

25 September 2017

Eremin O

series ordinal

3

1 reference

25 September 2017

publication date

1 April 1996

1 reference

European Journal of Surgical Oncology

25 September 2017

published in

1 reference

25 September 2017

volume

22

1 reference

25 September 2017

issue

2

1 reference

25 September 2017

page(s)

192-196

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

25 September 2017

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

1 reference

7 January 2021

Proceedings: Causes of death in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Regulation of tumor necrosis factor production in healthy humans and in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Measurement of tumour protein synthesis in vivo in human colorectal and breast cancer and its variability in separate biopsies from the same tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Combined hormonal infusion simulates the metabolic response to injury

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Both inflammatory and endocrine mediators stimulate host responses to sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

High Levels of Intracellular Bombesin Characterize Human Small-Cell Lung Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Pathophysiology of cancer: hormonal and metabolic abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Effect of systemic insulin on protein kinetics in postoperative cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Shock and tissue injury induced by recombinant human cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Tumour necrosis factor in man: clinical and biological observations

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Tumor necrosis factor and the acute metabolic response to tissue injury in man

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Cachectin/TNF production in experimental burns and Pseudomonas infection

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Cachectin: more than a tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Tumour necrosis factor and bacterial sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Cachectin and tumour necrosis factor as two sides of the same biological coin

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Tumor Necrosis Factor in the Malnutrition (Cachexia) of Infection and Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Tumors secreting human TNF/cachectin induce cachexia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Chronic TNF infusion causes anorexia but not accelerated nitrogen loss

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Induction of weight loss and metabolic alterations by human recombinant tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Acute-phase protein response and survival duration of patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Interleukin-6 and its relation to inflammation and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

1 reference

7 January 2021

Polyunsaturated fatty acids in the treatment of weight-losing patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

The role of prostaglandin E2 in immune suppression following injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Mechanisms of immunosuppression associated with severe nonthermal traumatic injuries in man: production of interleukin 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Decreased interleukin-2 production in patients with gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

Effect of low dose recombinant interleukin 2 plus indomethacin on mortality after sepsis in a murine burn model

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990905-1

7 January 2021

10.1016/S0748-7983(96)90905-1

Identifiers

DOI

1 reference

25 September 2017

1 reference